DRUG TRANSPORT IN THE KIDNEY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 484

40. Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T, Endou H. 2001. Iden-
tification and characterization of human organic anion transporter 3 expressing predom-
inantly in the kidney. Mol Pharmacol 59:1277-1286.
41. Kojima R, Sekine T, Kawachi M, Cha SH, Suzuki Y, Endou H. 2002. Immunolocalization
of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am
Soc Nephrol 13:848-857.
42. Nagata Y, Kusuhara H, Endou H, Sugiyama Y. 2002. Expression and functional charac-
terization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol Pharmacol
61:982-988.
43. Sweet DH, Miller DS, Pritchard JB, Fujiwara Y, Beier DR, Nigam SK. 2002. Impaired
organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3
(Slc22a8)) knockout mice. J Biol Chem 277:26934-26943.
44. Ohtsuki S, Kikkawa T, Mori S, Hori S, Takanaga H, Otagiri M, Terasaki T. 2004. Mouse
reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is
localized at abluminal membrane of blood-brain barrier. J Pharmacol Exp Ther 309:1273-
1281.
45. Jung KY, Takeda M, Kim DK, Tojo A, Narikawa S, Yoo BS, Hosoyamada M, Cha SH,
Sekine T, Endou H. 2001. Characterization of ochratoxin A transport by human organic
anion transporters. Life Sci 69:2123-2135.
46. Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T,
Endou H. 2002. Characterization of methotrexate transport and its drug interactions with
human organic anion transporters. J Pharmacol Exp Ther 302:666-671.
47. Sweet DH, Chan LM, Walden R, Yang XP, Miller DS, Pritchard JB. 2003. Organic
anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na +
gradient. Am J Physiol Renal Physiol 284:F763-F769.
48. Bakhiya A, Bahn A, Burckhardt G, Wolff N. 2003. Human organic anion transporter
3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. Cell Physiol
Biochem 13:249-256.
49. Cha SH, Sekine T, Kusuhara H, Yu E, Kim JY, Kim DK, Sugiyama Y, Kanai Y, Endou H.
2000. Molecular cloning and characterization of multispecific organic anion transporter
4 expressed in the placenta. J Biol Chem 275:4507-4512.
50. Ugele B, St-Pierre MV, Pihusch M, Bahn A, Hantschmann P. 2003. Characterization and
identification of steroid sulfate transporters of human placenta. Am J Physiol Endocrinol
Metab 284:E390-E398.
51. Babu E, Takeda M, Narikawa S, Kobayashi Y, Enomoto A, Tojo A, Cha SH, Sekine
T, Sakthisekaran D, Endou H. 2002. Role of human organic anion transporter 4 in the
transport of ochratoxin A. Biochim Biophys Acta 1590:64-75.
52. Anzai N, Enomoto A, Endou H. 2005. Renal urate handling: clinical relevance of recent
advances. Curr Rheumatol Rep 7:227-234.
53. Ekaratanawong S, Anzai N, Jutabha P, Miyazaki H, Noshiro R, Takeda M, Kanai Y,
Sophasan S, Endou H. 2004. Human organic anion transporter 4 is a renal apical or-
ganic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 94:297-
304.
54. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada
M, Takeda M, Sekine T, Igarashi T, et al. 2002. Molecular identification of a renal urate
anion exchanger that regulates blood urate levels. Nature 417:447-452.